Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Gynecology

Free Subscription Articles published in Hum Pathol Retrieve available abstracts of 25 articles: HTML format

Single Articles

October 2025
1. HOHN AK, Hiller GGR, Wolf B, Forberger M, et al
   Assessment of Nectin4-expression in vulvar squamous cell carcinomas (VSCC): correlation with HPV-associated and HPV-independent molecular subtypes.
   Hum Pathol. 2025;164:105926.
   PubMed     Abstract available
   
   
   August 2025
2. QIN L, Lin W, Huang S, Zheng W, et al
   High-grade endometrioid carcinomas with pilomatrix-like features lacking CTNNB1 Mutations: Clinicopathologic characteristics and novel molecular events.
   Hum Pathol. 2025;164:105928.
   PubMed     Abstract available
   
   
   July 2025
3. LEENEN S, Kooreman L, Bulten J, Esch EMGV, et al
   The occurrence and histopathological recognition of atypical endometriosis in patients with ovarian endometriosis - a retrospective cohort study.
   Hum Pathol. 2025 Jul 22:105875. doi: 10.1016/j.humpath.2025.105875.
   PubMed     Abstract available
   
   
   June 2025
4. LEI T, Liu B, Wei Y, Shi Y, et al
   Female reproductive tract inflammatory myofibroblastic tumor (IMT): A comprehensive analysis of clinicopathological and genomic features in a case series, including the identification of SERPINE1-ALK fusion in the fallopian tube.
   Hum Pathol. 2025;160:105839.
   PubMed     Abstract available
   
   
   
5. ZHONG F, Ren Z, Li W, Jones T, et al
   The sensitivity and specificity of Claudin18.2 and MUC6 in the differential diagnosis of endocervical gastric-type glandular lesions.
   Hum Pathol. 2025;160:105837.
   PubMed     Abstract available
   
   
   May 2025
6. TEKIN B, Cheville JC, Milosevic D, McCarthy M, et al
   Assessment of trophoblast cell-surface antigen 2 (TROP2) and nectin-4 expression in choriocarcinoma.
   Hum Pathol. 2025;159:105815.
   PubMed     Abstract available
   
   
   
7. ZHANG Y, Karimi SS, Requena DO, Khararjian A, et al
   Intestinal and liver involvement by endometrial stromal sarcoma: Expanding the differential diagnosis of mesenchymal tumors involving the GI tract.
   Hum Pathol. 2025;158:105784.
   PubMed     Abstract available
   
   
   
8. MILLER CH, Vemuri A, Lengyel E, Lastra RR, et al
   Adaptive immune response and PD-1/ PD-L1 status in chemotherapy treated high grade serous carcinoma is dependent on chemotherapy response score.
   Hum Pathol. 2025;159:105800.
   PubMed     Abstract available
   
   
   March 2025
9. HE D, Jin L, Geng H, Cao L, et al
   Deep learning-based analysis of gross features for ovarian epithelial tumors classification: A tool to assist pathologists for frozen section sampling.
   Hum Pathol. 2025;157:105762.
   PubMed     Abstract available
   
   
   
10. ZHANG Z, Shi H, Shao Y, Lu B, et al
    Clinicopathologic and molecular characterization of primitive neuroectodermal tumors (PNET) in the female genital tract: a retrospective study of 8 cases.
    Hum Pathol. 2025;157:105769.
    PubMed     Abstract available
    
    
    
11. ZHENG L, Tabet G, Guo CC, Rizvi YO, et al
    Clinicopathological study of 34 cases of clear cell adenocarcinoma of the urinary tract and diagnostic value of SOX 17 in its differential diagnosis.
    Hum Pathol. 2025;157:105767.
    PubMed     Abstract available
    
    
    January 2025
12. NODA Y, Tokuyama Y, Sumita W, Kita M, et al
    Hepatocyte nuclear factor 4alpha as a sensitive marker for uterine endocervical adenocarcinomas and their precursors.
    Hum Pathol. 2025;155:105714.
    PubMed     Abstract available
    
    
    
13. SCHOOLMEESTER JK, Gupta S, Boland JM, Al Kateb H, et al
    Ovarian Epithelioid Tumor with FUS::CREM Fusion and Multilineage Protein Expression: Report of a Case in the EWSR1/FUS-CREB Tumor Spectrum.
    Hum Pathol. 2025 Jan 8:105712. doi: 10.1016/j.humpath.2024.105712.
    PubMed    
    
    
    December 2024
14. KHAEFPANAH D, Zare S, Hasteh F, Shi WJ, et al
    Characterization of gastric/gastrointestinal-like immunophenotypes in endometrial endometrioid adenocarcinomas, including endometrioid adenocarcinomas with mucinous differentiation.
    Hum Pathol. 2024;154:105707.
    PubMed     Abstract available
    
    
    
15. ZHANG Y, Ju B, Cheng R, Ding T, et al
    PD-L1 expression and immune infiltration across molecular subtypes of endometrial cancer: An integrative-analysis of molecular classification and immune subtypes.
    Hum Pathol. 2024;154:105704.
    PubMed     Abstract available
    
    
    November 2024
16. ACOSTA AM, Fletcher CDM, Sholl LM, van Leenders GJ, et al
    Fluorescence in-situ hybridization assessment of spindle cell-rich testicular sex cord stromal tumors demonstrates multiple chromosomal gains across histologic subtypes.
    Hum Pathol. 2024;153:105652.
    PubMed     Abstract available
    
    
    October 2024
17. BROUARD M, Mobarki M, Peoc'h M, Karpathiou G, et al
    SALL4 expression is very rare in endometrial endometrioid and serous carcinoma.
    Hum Pathol. 2024 Oct 24:105675. doi: 10.1016/j.humpath.2024.105675.
    PubMed    
    
    
    
18. TABET GC, Zheng L, Hosseini H, Ward J, et al
    Epithelioid trophoblastic tumor in male patients with germ cell tumor: A clinicopathologic analysis of five cases.
    Hum Pathol. 2024 Oct 24:105673. doi: 10.1016/j.humpath.2024.105673.
    PubMed     Abstract available
    
    
    
19. DASHTI NK, Swanson AA, Bentz J, Xing D, et al
    DICER1-sarcomas of GYN tract: Expanding on an emerging entity.
    Hum Pathol. 2024;152:105636.
    PubMed     Abstract available
    
    
    September 2024
20. KEENEY M, Keeney GL, Cheville JC, Gupta S, et al
    VHL-mutated papillary cystadenoma of the mesosalpinx with omental tumor deposits and immunophenotypic overlap with mesothelioma.
    Hum Pathol. 2024;151:105617.
    PubMed    
    
    
    August 2024
21. NAKAJIMA J, Yano M, Zaitsu S, Kamada K, et al
    Therapeutic indications for antibody-drug conjugates estimated from HER2 and p53 expressions in endometrial carcinoma.
    Hum Pathol. 2024 Aug 16:105649. doi: 10.1016/j.humpath.2024.105649.
    PubMed     Abstract available
    
    
    July 2024
22. ZELISSE HS, Dijk F, van Gent MDJM, Hooijer GKJ, et al
    Improving histotyping precision: the impact of immunohistochemical algorithms on epithelial ovarian cancer classification.
    Hum Pathol. 2024 Jul 29:105631. doi: 10.1016/j.humpath.2024.105631.
    PubMed     Abstract available
    
    
    May 2024
23. NAVARRO SANCHEZ JM, Finkelman BS, Tyburski H, Turner BM, et al
    Performance of HER2 DAKO HercepTest and Ventana 4B5 Immunohistochemical Assays on Detecting HER2 Gene-Amplification in Uterine Serous Carcinomas.
    Hum Pathol. 2024 May 11:S0046-8177(24)00086.
    PubMed     Abstract available
    
    
    April 2024
24. NGO C, Cotteret S, Deneche I, Kfoury M, et al
    Uterine adenosarcoma: clinical significance of histological classification and SNP array analysis.
    Hum Pathol. 2024 Apr 28:S0046-8177(24)00083.
    PubMed     Abstract available
    
    
    
25. GUPTA S, Schoolmeester JK, Cheville JC
    Expanding the Spectrum of Paratesticular Mullerian-Origin Tumors: Adenocarcinoma with Mixed Serous and Endometrioid Features and Clear Cell Carcinoma.
    Hum Pathol. 2024 Apr 27:S0046-8177(24)00060.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.